Skip to content
Why you as an healthcare advisor should join us…
The best event to grow your healthcare advisor business and deepen your knowledge of international health care services is HBI 2023.
Healthcare Business International, now in its thirteenth year, is the only CEO-level event for the sector across Europe and Emerging Markets. In 2022 we had several hundred CEO/CXOs from major operators and over 150 investors.
4 Top reasons why leading healthcare advisors attend:
As an adviser in health care services, no matter where you are in the world, you should join them in 2023.
Superb networking
This is a rare opportunity to meet a wide range of operators at CEO and CXO level. We don’t think you will find as many specialist investors in health care services at any event outside of the USA.
Insights that top up your expertise
It’s hard to keep up with developments in this high growth, fast-moving sector. Nowhere is better than HBI 2023 for provoking new thinking. Our CEO speakers deliver real insights into everything from workforce to M&A and from marketing to how groups are really using digital.
The broader vision you need
You, personally, need to understand this sector internationally. Nowhere else offers such a view of the landscape. This event focuses on sectors such as elderly care, hospitals and diagnostics AND gives you insights at regional level.
Any questions? Call us now on 00 44 207 183 3779
Here is why advisers from national players to the global strategy firms attend:
Perhaps it is not surprising that many healthcare advisors send CXO teams. Now, book your place at HBI 2023.
After previous years people have come up to me afterwards and said, will you sell our company? Which is great and it made attendance incredibly worthwhile financially. It’s great to do is have a five minute conversation which will then lead to having a deeper conversation at a later point. It's that ability to talk to loads of people. You meet a whole bunch of companies you've never met before and the ability to take that away and revisit that in your own time.
Hedley Goldberg, Managing Director Rothschild & Co
What struck me was the availability of some of the brightest minds in health care. I get to meet a lot of people in a very fluid way which I could not do anywhere else.
Ronnie Van der Merwe, CEO, Mediclinic
A very interesting conference which is focussed on health care and you don’t find that elsewhere. You find a lot of operators and new ideas. The networking is all about human relationships and the magic of it is here.
Frederic Dib, Mozaic Asset Management, France, Europe
Very useful with a good mix of presentations and panel discussions. Excellent levels of networking with many people in senior positions to meet.
Frederik Gren, CEO, Ambea
Quality participants at CEO and CXO level from large companies with relevant private equity firms present. Well organized, engaging presentations and panel discussions.
Petri Heikila, Senior Manager, Nordic Healthcare Group
I get a better view of what is going on with digital health, artificial intelligence and how the providers and payors manage within the global trends. And also their cost-cutting initiatives. I’ve never had the chance to meet other CFOs and CEOs from other private hospitals. I am meeting many of them here. I'll be catching up with them, touching base with them afterwards. It's a great experience and a great networking opportunity.
Burcu Öztürk, CFO, MLP Care
Wonderful forward thinking visions offered by speakers, enhanced by great networking.
Dr Michelle Tempest, Partner, Candesic
A very well organised conference. I managed to meet a lot of useful peers from the sector.
Luc Deschamps, Partner, Strategy Partners Group
Final discount saving ends in...
See who is attending
Featured Speakers
Sessions include:
Tuesday June 20, 2023
Investing in Europe
How do major investors in the sector view the challenges it faces? How do they view environmental, societal and governance issues? In which sectors and countries do they see opportunities?
Martin Henrichs, Head of Healthcare EMEA, UBS
Nikolaus Woloszczuk, Senior Managing Partner, Stonepeak
Inaki Cobo, Partner, Private Equity, KKR
Viviana Kane, Managing Director, EQT Partners
Moderated by Max Hotopf, Founder and Chairman, HBI
Tuesday June 20, 2023
Investing in Emerging Markets
Bearing the brunt of inadequate health systems, low and middle-income countries are ripe for investment opportunities from the private sector. This session with leading emerging market investors outlines the challenges and the opportunities for investment, growth and innovation.
Speakers include:
Amaury Guerrero, CEO, Opty / Patria Group
Zeynep Kantur, Global Manager & Global Head of Health, IFC
Afsane Jetha, Managing Partner & CEO, Alta Semper Capital
Jide Olanrewaju, Managing Director, TPG Rise
Moderated by Max Ateba, Associate Partner, Dalberg Advisors
Tuesday June 20, 2023
Investing in UK and Ireland
The UK remains by far the largest market for private equity investment in Europe. But what are the dynamics post-Covid and post-Brexit? A wide-ranging exploration with expert advisors, investors and operators discussing the region’s investment opportunities, growth sectors and regulatory environment.
Speakers include:
Katie Beckingham, Director, August Equity LLP
Alan Hughes, Founder, LIT Healthcare
James Tugendhat, CEO, HC-One
Dr Charles Niehaus, Executive Director, Affidea Group
Moderated by Sharon Lamb, Partner, McDermott, Will & Emery
Tuesday June 20, 2023
Investing in Health Care Property
A conversation with some of the largest health care property investors discussing topics such as: How robust is health care real estate to rising inflation? What ESG frameworks are in place and what is lacking? What impact is the lack of available debt having on transactions?
Speakers include:
Stephane Pichon, Founder and Managing Partner, Your Care Consult
Steve Nitschke, Managing Director, Head of European Acquisitions, MPT
Xavier Cheval, CEO, Icade
Moderated by Hugh Risebrow, Managing Director, Latchmore Associates
Tuesday June 20, 2023
Investing in DACH
The 100m population of wealthy German-speaking countries is by far the largest market for healthcare services in Europe. What will be the trajectory for future consolidation, who are the players and what is the opportunity? A wide-ranging exploration with expert advisors, investors and operators discussing the region’s investment opportunities, growth sectors and regulatory environment.
Speakers include:
Andreas Ludowig, CEO, Kinios
Dirk Knueppel, CEO, Primärmedizin TMVZ GmbH
Julius Hugelshofer, Senior Principal, Verlinvest
Dr Axel Paeger, CEO, Ameos Hospital Group
Moderated by Dr Stephan Rau, Partner, McDermott, Will & Emery
Backed by Triton Partners, Kinios is consolidating the German outpatient orthopaedic space. Leveraging the scale of Kielstein group, Germany’s largest primary care network, Primarmedizin is looking to build an outpatient network specialising in internal medicine.
Wednesday June 21, 2023
Opportunities in Nursing Homes
Growth projections have always been difficult in the elderly care sector – and now even challenged as a result of Covid- 19 and scandals which rocked the sector in 2022. Our panel of experts share their views on the opportunities and challenges as we look ahead to the next 3 years.
Speakers include:
Buyanzaya Batbileg, Head of Investment, Threestones Capital Investment
Threestones has three funds totalling more than a billion Euros investing in nursing homes in Germany, Italy and Spain
Nate McLemore, Managing Director, Columbia Pacific Management
Dr Sanjeev Kanoria, Founder and Chairman, Advinia Health Care
Moderated by Michaila Byrne, Senior Analyst, HBI
Wednesday June 21, 2023
The Outpatient Differential
Traditional hospitals face massive change. The drive towards outpatient and the creation of virtual wards promises to reduce costs and grow supply. This session looks at how and why outpatient models will shape the future of healthcare delivery globally with real data and examples of cost savings, efficiency increase and patient satisfaction.
Speakers include:
Chris Robson, Managing Director, Akeso&Co
Chris is working with NHS England to implement 40-50 virtual beds per 100,000 people. He shares the lessons learned implementing such wards, the technology required and the early outcomes from projects.
Zisis Sotiriou, Senior Vice President, Regional COO, Affidea
Vivek Shukla, Managing Partner, Surge Management Consulting
Wednesday June 21, 2023
Opportunities in Mental Health
The world faces a mental health pandemic. How far can this be met by digital therapeutics and how can operators consolidate this fragmented sector? And how far are more acute psychiatric needs being addressed in the for-profit sector? Participants include Andre Schmidt, Group CEO Median, the biggest German rehabilitation group which acquired the Priory, the UK’s largest mental health provider in late 2020 and Petri Bono, CMO at Terveystalo, which has reduced mental health absences at client companies by 40%.
Speakers include:
Petri Bono, Chief Medical Officer, Terveystalo
Petri shares how Finlands largest private health and occupational health group developed new, cost efficient patient pathways that lead to a 40% decrease in mental health absences.
Dr Andre Schmidt, Group CEO, MEDIAN
Alexandra Prieux, CEO, ALCEDIAG
Simon Miller, International Partnerships Lead, Headspace Health
Moderated by Dr Stefan Schrettle, Partner, L.E.K. Consulting
Wednesday June 21, 2023
The evolution in Primary Care
The huge primary care sector in Europe holds the key to outpatient consolidation. Here we look at how operators are pairing it with digital and telehealth, pharmacies and imaging, and at how they are reimagining its delivery and business models.
Speakers include:
Dr Murray Ellender, CEO and Co-Founder, eConsult Health
Lyndsey Reeves, Director of Operations UK, Kry Livi
Dirk Knueppel, CEO, Primärmedizin TMVZ GmbH
Martin Lindman, CEO, Doktor.Se
Moderated by Martin Debenito-Gellner, Senior Analyst, HBI
Wednesday June 21, 2023
Opportunities in Oncology
There is still a long way to go to build capacity in oncology care, but with huge investor interest, linked to the close synergies with imaging diagnostics, the opportunities are huge. Add in public sector outsourcing and there’s a lot of room for growth. This session explores the opportunities and analyses the best models to build capacity. Ralf Kurek heads up one of the largest players in the sector internationally.
Speakers include:
Dr Ralf Kurek, Executive Partner, RadioOnkologieNetzwerk, Ergéa Group
Ralph Hefti, CEO, Stingray Healthcare
Moderated by Joe Quiruga, Analyst, HBI
Radiotherapy and outpatient oncology is another key sector for consolidation across Europe with investors such as DWS, owners of RON through Medipass, and Infravia building Pan-European chains. Here Ralf takes the lid off RON’s business model
Wednesday June 21, 2023
The investment opportunity in fertility and women’s health
The fertility sector continues to steadily grow, but with a fragmented market, consolidation is not straightforward. And the revolution to address health inequalities for women presents a huge opportunity – around fertility, pregnancy and the menopause. Meanwhile femtech is set to be a $50bn industry by 2025. This session looks in depth at future growth prospects with speakers from two of the largest international consolidators – Virtus and TFP.
Speakers include:
Richard Banks, Group Chief Strategy Officer & European Managing Director, Virtus Health
Australian-based fertility group, Virtus was the subject of a bidding war in 2022 highlighting the growth opportunity in fertility services. With 25 clinics in the UK, Denmark, Netherlands, Poland, Austria and Germany the Impilo owned group is focussed on dominating the northern European market.
Johannes Roehren, Group CEO, TFP Fertility
Katya Zubareva, Partner, L.E.K. Consulting
Annie Coleridge, Product Director, Corporate, SimplyHealth
Moderated by Hugh Risebrow, Managing Director, Latchmore Associates
Wednesday June 21, 2023
Opportunities in Oncology
There is still a long way to go to build capacity in oncology care, but with huge investor interest, linked to the close synergies with imaging diagnostics, the opportunities are huge. Add in public sector outsourcing and there’s a lot of room for growth. This session explores the opportunities and analyses the best models to build capacity. Ralf Kurek heads up one of the largest players in the sector internationally.
Speakers include:
Dr Ralf Kurek, Executive Partner, RadioOnkologieNetzwerk, Ergéa Group
Ralph Hefti, CEO, Stingray Healthcare
Moderated by Joe Quiruga, Analyst, HBI
Radiotherapy and outpatient oncology is another key sector for consolidation across Europe with investors such as DWS, owners of RON through Medipass, and Infravia building Pan-European chains. Here Ralf takes the lid off RON’s business model